Elite Pharmaceuticals Inc (ELTP)
0.5177
-0.06
(-9.98%)
USD |
OTCM |
Nov 14, 16:00
Elite Pharmaceuticals Net Income (TTM): 19.58M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 19.58M |
| March 31, 2024 | 20.11M |
| December 31, 2023 | 15.55M |
| September 30, 2023 | 17.82M |
| June 30, 2023 | 4.398M |
| March 31, 2023 | 3.562M |
| December 31, 2022 | 7.220M |
| September 30, 2022 | 6.533M |
| June 30, 2022 | 6.815M |
| March 31, 2022 | 8.898M |
| December 31, 2021 | 5.987M |
| September 30, 2021 | 5.716M |
| June 30, 2021 | 6.400M |
| March 31, 2021 | 5.088M |
| December 31, 2020 | 6.507M |
| September 30, 2020 | 2.635M |
| June 30, 2020 | -1.443M |
| March 31, 2020 | -2.240M |
| December 31, 2019 | -5.840M |
| September 30, 2019 | -6.324M |
| June 30, 2019 | -7.312M |
| March 31, 2019 | -9.279M |
| December 31, 2018 | -9.445M |
| September 30, 2018 | -7.591M |
| June 30, 2018 | -3.192M |
| Date | Value |
|---|---|
| March 31, 2018 | -3.673M |
| December 31, 2017 | -4.034M |
| September 30, 2017 | -1.877M |
| June 30, 2017 | 0.5459M |
| March 31, 2017 | 3.809M |
| December 31, 2016 | 15.50M |
| September 30, 2016 | 1.598M |
| June 30, 2016 | -4.321M |
| March 31, 2016 | -0.683M |
| December 31, 2015 | -15.53M |
| September 30, 2015 | 4.117M |
| June 30, 2015 | 12.05M |
| March 31, 2015 | 5.221M |
| December 31, 2014 | -19.91M |
| September 30, 2014 | -28.39M |
| June 30, 2014 | -44.28M |
| March 31, 2014 | -41.26M |
| December 31, 2013 | -8.181M |
| September 30, 2013 | 2.244M |
| June 30, 2013 | 12.93M |
| March 31, 2013 | 1.488M |
| December 31, 2012 | -7.114M |
| September 30, 2012 | -7.716M |
| June 30, 2012 | 5.153M |
| March 31, 2012 | -15.06M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-5.840M
Minimum
Dec 2019
20.11M
Maximum
Mar 2024
7.016M
Average
6.400M
Median
Jun 2021
Net Income (TTM) Benchmarks
| Biomarin Pharmaceutical Inc | 322.29M |
| BioCardia Inc | -8.559M |
| Zevra Therapeutics Inc | -65.74M |
| Verrica Pharmaceuticals Inc | -84.99M |
| Terns Pharmaceuticals Inc | -95.90M |